Two-part cyanoacrylate curable adhesive system

1. A two-part curable composition comprising:

(a) a first part comprising a cyanoacrylate composition comprising:

a cyanoacrylate component, and

a rubber toughening agent comprised of (i) reaction products of the combination of ethylene, methyl acrylate and monomers having carboxylic acid cure sites, (ii) dipolymers of ethylene and methyl acrylate, and combinations of (i) and (ii); and

(b) a second part comprising:

a 2-substituted benzothiazole or derivative thereof, wherein the 2-substitutent is a C 1-20 alkyl, a C 2-20 alkene, a C 8-20 alkylbenzyl, a C 1-20 alkylamino, a C 1-20 alkoxy, a C 1-20 alkylhydroxy, an ether, a sulfenamide, a C 1-20 thioalkyl or a C 1-20 thioalkoxy group; and

wherein at least one of the first or the second part further comprises one or more of:

a component containing at least two (meth)acrylate functional groups,

at least one benzonitrile compound substituted with at least two or more electron withdrawing groups selected from halo, —NO 2 , or —CN and combinations thereof, and

at least one anhydride component.

2. The two-part curable composition according to claim 1 wherein the cyanoacrylate component is represented by H 2 C═C(CN)—COOR, wherein R is selected from C 1-15 alkyl, C 2-15 alkoxyalkyl, C 3-15 cycloalkyl, C 2-15 alkenyl, C 6-15 aralkyl, C 5-15 aryl, C 3-15 allyl and C 1-15 haloalkyl groups.

3. The two-part curable composition according to claim 2 , wherein the cyanoacrylate component comprises ethyl-2-cyanoacrylate.

4. The two-part curable composition according to claim 1 , wherein the 2-substituted benzothiazole is further substituted with at least one halo, C 1-20 thioalkyl, C 1-20 haloalkyl, C 1-20 alkyl, C 1-20 alkoxy or hydroxyl substituent.

5. The two-part curable composition according to claim 4 , wherein the halo substituent is Cl, F or Br.

6. The two-part curable composition according to claim 1 , wherein the 2-substituted benzothiazole is selected from the group consisting of: 5-chloro-2-methyl benzothiazole, 5-bromo-2-methyl-1,3-benzothiazole, 2-[(tert-butylamino)thio]-1,3-benzothiazol-5-ol, 5,6-dichloro-2-methyl-1,3-benzothiazole, 6-bromo-2-methyl-1,3-benzothiazole, 5-fluoro-2-methyl-1,3-benzothiazole, 6,7-dichloro-2-methyl-1,3-benzothiazole, 2,5-dimethyl-1,3-benzothiazole, 4,5,6,7-tetrafluoro-2-methyl-1,3-benzothiazole, 4,5,6,7-tetrafluoro-2-methyl-1,3-benzothiazole, 2-(allyloxy)-1,3-benzothiazole 2-methyl-5-(methylthio)-1,3-benzothiazole, 2-(ethylthio)-1,3-benzothiazole, 2-(hexyloxy)-1,3-benzothiazole, 2-(1,3-dimethylbutoxy)-1,3-benzothiazole, 2-(Octadecylthio)benzothiazole, 2-(1-ethylbutoxy)-1,3-benzothiazole, 2-(octyloxy)-1,3-benzothiazole, 2-(1-methylbutoxy)-1,3-benzothiazole, 2-(2-phenylethoxy)-1,3-benzothiazole, 2-[(1-methylheptyl)oxy]-1,3-benzothiazole 2-allyl-1,3-benzothiazole, 2-[(1-methylhexyl)oxy]-1,3-benzothiazole, 4-chloro-2-methoxy-1,3-benzothiazole, 2-(3-methylbutoxy)-1,3-benzothiazole, 4-chloro-2-(ethynyloxy)-1,3-benzothiazole, 2,5,6-trimethyl-1,3-benzothiazole, 4-methoxy-2,7-dimethyl-1,3-benzothiazole, 5,6-dimethoxy-2-methyl-1,3-benzothiazole, 2,5,7-trimethyl-1,3-benzothiazole, 2-(butylthio)-1,3-benzothiazole, 5-chloro-2-(ethylthio)-1,3-benzothiazole, 2-methyl-1,3-benzothiazole, 2-(undecylthio)-1,3-benzothiazole, 2-methyl-1,3-benzothiazole 5-methoxy-2-methylbenzothiazole, 2,5-dimethylbenzothiazole 6-methoxy-2-methylbenzothiazole, 2-methyl-5-benzothiazolol, 2-(methylmercapto)-benzothiazole, and 2-[(cyclohexylamino)thio]-benzothiazole).

7. The two-part curable composition according to claim 6 , wherein the 2-substituted benzothiazole is selected from the group consisting of: 5-chloro-2-methyl benzothiazole, 2-methyl-1,3-benzothiazole, 2-(methylmercapto)-benzothiazole, 5-methoxy-2-methylbenzothiazole, 6-methoxybenzothiazole, 2,5-dimethylbenzothiazole and 2-methyl-5-benzothiazolol.

8. The two-part curable composition according to claim 1 , wherein the component containing at least two (meth)acrylate functional groups is represented by the formula:

wherein A is a C 4 to C 30 aliphatic chain which can optionally comprise heteroatoms selected from the group consisting of O, N and S;

wherein said chain is optionally substituted with one or more acrylate or methacrylate functional groups, and/or one or more C 1 -C 10 alkyl groups; and

wherein R 1 and R 2 may be the same or different and are each optionally selected from the group consisting of H and C 1 to C 6 alkyl.

9. The two-part curable composition according to claim 1 , wherein the component containing at least two (meth)acrylate functional groups is selected from the group consisting of hexane diol diacrylate, hexane diol dimethacrylate, and di-trimethylolpropane tetraacrylate and combinations thereof.

10. The two-part curable composition according to claim 1 , wherein the component containing at least two (meth)acrylate functional groups is in the second part (b).

11. The two-part curable composition according to claim 1 , wherein the anhydride component is selected from the group consisting of: phthalic anhydride, tetrahydrophthalic anhydride, 4-methylphthalic anhydride, itaconic anhydride, diphenic anhydride, phenylsuccinic anhydride, 1,8 naphthalic anhydride, bromomaleic anhydride, 2,3-dichloromaleic anhydride, 2-dodecen-1-yl-succinic anhydride, homophthalic anhydride, tetrabromophthalic anhydride, bicyclo[2,2,2]oct-7-ene 2,3,5,6-tetracarboxylic dianhydride, 3-fluorophthalic anhydride, 3,3,4,4-benzophenone tetracarboxylic dianhydride, 3-nitrophthalic anhydride, 3,3,4,4-biphenyltetracarboxylic dianhydride, pyromellitic dianhydride, 1,4,5,8 naphthalene tetracarboxylic dianhydride, methacrylic anhydride, citraconic anhydride, hexahydro-4-methylphthalic anhydride, maleic anhydride, 2,3-diphenylmaleic anhydride, hexafluoroglutaric anhydride, 2,3-dimethylmaleic anhydride, tetrafluorophthalic anhydride, 1,2-cyclohexanedicarboxylic anhydride, glutaric anhydride, bromomaleic anhydride, 1,4,5,8-napthalenetetracarboxylicacid dianhydride, 1,2,4-benzenetricarboxylic anhydride, Exo-3,6-epoxy-1,2,3,6-tetrahydrophthalic anhydride, di-O-acetyl-L-tartaric anhydride, 1,2,4,5-benzenetetracarboxylic dianhydride, 1,2,4-benzenetricarboxylic anhydride and combinations thereof.

12. The two-part curable composition according to claim 1 , wherein the benzonitrile compound is selected from the group consisting of: tetrafluoroisophthalonitrile, 3,5-dinitrobenzonitrile; 2-chloro-3,5-dinitrobenzonitrile; pentafluorobenzonitrile; α,α,α-2-tetrafluoro-p-tolunitrile; and tetrachloroterphthalonitrile and combinations thereof.

13. The two-part curable composition according to claim 1 , wherein the benzonitrile compound is present in an amount of from 0.05 to 5 wt %, based on the total weight of the composition.

14. The two-part curable composition according to claim 1 , wherein the anhydride component is present in an amount of from 0.1 to 5 wt %, based on the total weight of the composition.

15. The two-part curable composition according to claim 1 , wherein the component containing at least two (meth)acrylate functional groups is present in an amount of from 1 to 20 wt %, based on the total weight of the composition.

16. The two-part curable composition according to claim 1 , wherein the 2-substituted benzothiazole is 5-chloro-2-methyl benzothiazole, the anhydride is selected from the group consisting of phthalic anhydride, tetrahydrophthalic anhydride, itaconic anhydride or 4-methylphthalic anhydride and combinations thereof, and wherein the at least one benzonitrile compound is selected from the group consisting of tetrafluoroisophthalonitrile or pentafluorobenzonitrile and combinations thereof.

17. The two-part curable composition according to claim 16 wherein the benzonitrile is present in an amount of from 0.1 to 1 wt %, the anhydride is present in an amount of from 0.1 to 2 wt %, and the component containing at least two (meth)acrylate functional groups is present in an amount of from 4 to 12 wt %, based on the total weight of the composition.

18. The two-part curable composition according to claim 1 , further comprising an accelerator component selected from the group consisting of calixarene, oxacalixarene, silacrown, cyclodextrin, crown ether, poly(ethyleneglycol) di(meth)acrylate, ethoxylated hydric compound, and combinations thereof.

19. The two-part curable composition according to claim 18 , wherein the accelerator component comprises a calixarene which is tetrabutyl tetra[2-ethoxy-2-oxoethoxy]calix-4-arene.

20. The two-part curable composition according to claim 18 , wherein the accelerator component comprises a crown ether which is selected from the group consisting of 15-crown-5, 18-crown-6, dibenzo-18-crown-6, benzo-15-crown-5-dibenzo-24-crown-8, dibenzo-30-crown-10, tribenzo-18-crown-6, asym-dibenzo-22-crown-6, dibenzo-14-crown-4, dicyclohexyl-18-crown-6, dicyclohexyl-24-crown-8, cyclohexyl-12-crown-4, 1,2-decalyl-15-crown-5, 1,2-naphtho-15-crown-5, 3,4,5-naphtyl-16-crown-5, 1,2-methyl-benzo-18-crown-6, 1,2-methylbenzo-5, 6-methylbenzo-18-crown-6, 1,2-t-butyl-18-crown-6, 1,2-vinylbenzo-15-crown-5, 1,2-vinylbenzo-18-crown-6, 1,2-t-butyl-cyclohexyl-18-crown-6, asym-dibenzo-22-crown-6, and 1,2-benzo-1,4-benzo-5-oxygen-20-crown-7 and combinations thereof.

21. The two-part curable composition according to claim 18 , wherein the accelerator component comprises a poly(ethyleneglycol) di(meth)acrylate represented by the following structure:

wherein n is greater than 3.

22. The two-part curable composition according to claim 1 , further comprising additives selected from the group consisting of shock resistant conferring additives, thixotropy conferring agents, thickeners, dyes, thermal degradation resistance enhancers, and combinations thereof.

23. The two-part curable composition according to claim 22 , wherein the shock resistant conferring additive is citric acid.

24. The two-part curable composition according to claim 1 , further comprising at least one additive selected from the group consisting of: 2-sulfobenzoic acid anhydride, triethylene glycol di(paratoluene sulfonate), trifluoroethyl para-toluene sulfonate, dimethyl dioxolen-4-ylmethyl para-toluene sulfonate, paratoluene sulfonic anhydride, methane sulfonic anhydride, 1,3-propylene sulfite, dioxathiolene dioxide, 1,8-naphthosultone, sultone 1,3-propane, sultone 1,4-butene, allyl phenyl sulfone, 4-fluorophenyl sulfone, dibenzothiophene sulfone, bis(4-fluorophenyl) sulfone, ethyl p-toluenesulfonate, trifluoromethanesulfonic anhydride, ethylene sulphite and combinations thereof.

25. The two-part curable composition according to claim 24 , wherein the additive is selected from 1,8-naphthosultone and ethylene sulphite, and combinations thereof.

26. The two-part curable composition according to claim 1 , wherein the weight ratio of the first part to second part is in the range of 1:1 to about 10:1.

27. The two-part curable composition according to claim 26 , wherein the weight ratio of the first part to second part is selected from about 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1 or 10:1.

28. The two-part curable composition according to claim 1 , wherein the component containing at least two (meth)acrylate functional groups is used as a carrier material for the at least one benzonitrile compound.

29. A method of bonding together two substrates, comprising the steps of:

applying a two-part curable composition according to claim 1 , to at least one of the substrates and mating together the substrates for a time sufficient to permit an adhesive bond to form from the cyanoacrylate composition between the mated substrates.

30. A two-part curable composition comprising:

(a) a first part comprising a cyanoacrylate composition comprising:

a cyanoacrylate component, and

a rubber toughening agent comprised of (i) reaction products of the combination of ethylene, methyl acrylate and monomers having carboxylic acid cure sites, (ii) dipolymers of ethylene and methyl acrylate, and combinations of (i) and (ii); and

(b) a second part comprising:

a 2-substituted benzothiazole or derivative thereof, wherein the 2-substitutent is a C 1-20 alkyl, a C 2-20 alkene, a C 8-20 alkylbenzyl, a C 1-20 alkylamino, a C 1-20 alkoxy, a C 1-20 alkylhydroxy, an ether, a sulfenamide, a C 1-20 thioalkyl or a C 1-20 thioalkoxy group; and

wherein at least one of the first or second part further comprises:

an anhydride component; and

wherein the second part further comprises:

a component containing at least two (meth)acrylate functional groups which is present in an amount of from 1 to 20 wt %, based on the total weight of the composition; and

at least one benzonitrile compound substituted with at least two or more electron withdrawing groups selected from halo, —NO 2 , or —CN and combinations thereof.

31. The two-part curable composition according to claim 30 , wherein the 2-substituted benzothiazole is selected from the group consisting of: 5-chloro-2-methyl benzothiazole, 2-methyl-1,3-benzothiazole, 2-(methylmercapto)-benzothiazole, 5-methoxy-2-methylbenzothiazole, 6-methoxybenzothiazole, 2,5-dimethylbenzothiazole and 2-methyl-5-benzothiazolol and combinations thereof;

the anhydride component is selected from the group consisting of: tetrafluoroisophthalonitrile, 3,5-dinitrobenzonitrile; 2-chloro-3,5-dinitrobenzonitrile; pentafluorobenzonitrile; α,α,α-2-tetrafluoro-p-tolunitrile; and tetrachloroterphthalonitrile and combinations thereof; and

the component containing at least two (meth)acrylate functional groups is selected from the group consisting of hexanediol diacrylate, hexanediol dimethacrylate, and di-trimethylolpropane tetraacrylate and combinations thereof.

32. Cured reaction products of a two-part curable composition comprising:

(a) a first part comprising a cyanoacrylate composition comprising:

a cyanoacrylate component, and

a rubber toughening agent comprised of (i) reaction products of the combination of ethylene, methyl acrylate and monomers having carboxylic acid cure sites, (ii) dipolymers of ethylene and methyl acrylate, and combinations of (i) and (ii); and

(b) a second part comprising:

a 2-substituted benzothiazole or derivative thereof, wherein the 2-substitutent is a C 1-20 alkyl, a C 2-20 alkene, a C 8-20 alkylbenzyl, a C 1-20 alkylamino, a C 1-20 alkoxy, a C 1-20 alkylhydroxy, an ether, a sulfenamide, a C 1-20 thioalkyl or a C 1-20 thioalkoxy group; and

wherein at least one of the first or second part further comprises:

a component containing at least two (meth)acrylate functional groups,

at least one benzonitrile compound substituted with at least two or more electron withdrawing groups selected from halo, —NO 2 , or —CN and combinations thereof, and at least one anhydride component.